West Pharmaceutical Services (WST) Other Working Capital Changes (2016 - 2026)
West Pharmaceutical Services has reported Other Working Capital Changes over the past 18 years, most recently at $102.9 million for Q1 2026.
- Quarterly Other Working Capital Changes rose 103000.0% to $102.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $93.3 million through Mar 2026, up 262.83% year-over-year, with the annual reading at -$9.7 million for FY2025, 57.08% up from the prior year.
- Other Working Capital Changes was $102.9 million for Q1 2026 at West Pharmaceutical Services, up from -$11.6 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $102.9 million in Q1 2026 and troughed at -$185.4 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is $100000.0 (2024), against an average of $2.2 million.
- Biggest five-year swings in Other Working Capital Changes: tumbled 2200.0% in 2025 and later surged 103000.0% in 2026.
- Tracing WST's Other Working Capital Changes over 5 years: stood at -$185.4 million in 2022, then soared by 85.98% to -$26.0 million in 2023, then plummeted by 66.15% to -$43.2 million in 2024, then skyrocketed by 73.15% to -$11.6 million in 2025, then soared by 987.07% to $102.9 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods came in at $102.9 million, -$11.6 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.